Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

View:
Post by PeterG on Jan 07, 2023 4:20am

Q&A

Vancouver, British Columbia – January 6, 2023 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that we will host an update via webinar on January 17th 2023 at 10:00 AM – 11:00 AM PST.

The update will be followed by a Q&A session for attendees. Registration is required. To register, please click the below link:

https://teams.microsoft.com/registration/5BRnFaU7QEOktevE4vPEBA,h1k7nJkSbkmBl0AhUfx8oQ,G6SzvadNi0-Qxa2NcSxFYQ,u6muRz-4-UC0DCA7pV5UYg,yY1u2LycxU-yVd6uDSwHbg,re5LRD3zik-v3NdotOfRkQ?mode=read&tenantId=156714e4-3ba5-4340-a4b5-ebc4e2f3c404

The webinar will be a view & listen-only webinar for all attendees, where only we are visible and able to be heard, and all participants' privacy is completely protected (your camera & mic will be turned off). The Q&A functionality allows anyone to ask a question as we will poll for questions at the end at the end of the update.


For more information, please contact
Michelle Seltenrich
mseltenrich@sironabiochem.com 

Comment by navajojoe on Jan 07, 2023 12:00pm
This post has been removed in accordance with Community Policy
Comment by biorun on Jan 07, 2023 1:03pm
polling in this context means that questions will come forward but then polling or "voting by participants " will be done and the most popular questions will be addressed in priority. slido is one such way of accomplishing this.
Comment by navajojoe on Jan 07, 2023 2:52pm
This post has been removed in accordance with Community Policy
Comment by biorun on Jan 07, 2023 6:48pm
you obviously don't work in the modern corporate world.
Comment by navajojoe on Jan 07, 2023 7:38pm
This post has been removed in accordance with Community Policy
Comment by MirrorWorldMan on Jan 08, 2023 2:00pm
Make some popcorn and watch the spinning fiction
Comment by forhandlaren on Jan 09, 2023 7:39am
Not sure why they suddenly choose to start communicating, but one thing I've learned over the years is that the management step forward only when a positive or neutral massage will be delivered. Hence the absence this autumn and winter. The summer promises have not been delivered - at least not to the public. Will they release something substantial before the Q&A? Why expose themselves ...more  
Comment by Pareto8020 on Jan 09, 2023 7:49am
I think they must have some news coming out prior as well - otherwise Howie wouldn't want to subject himself to questions from the unwashed masses about "his" company or performance or lack there of.   First question should be what happened to that explosive growth forecast for H2 of 2022 vs. the stock being crushed to 52 week lows?  Second question is why after years ...more  
Comment by MirrorWorldMan on Jan 09, 2023 9:23am
Adding some colour to revenue forecasts and timeline to profitability is also critical. What about R(ipoff) + F (ake) sales. Is that deal over, why so little revenue? Howie has run out of fingers to put into the damn and the stock is sinking on zero management performance and marginal income. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities